Maia Pharmaceuticals, Inc. et al. vs Bracco Diagnostics Inc.

Notice of Refund

Petitioner's Request for Refund of Post-Institution Fees

Trial Instituted Document

Amended Joint Claim Construction and Prehearing Statement

Bracco's Responses to Invalidity Contentions

Bracco's Opening Markman Brief

Bracco's Expert Declaration Concerning Markman Brief

Maia's Expert Declaration Concerning Markman Brief

US Patent No. 5,574,136

US Patent Application Publication No. 2019/0060240

Original (as filed) claims of US2019/0060240

Response to Office Action filed Feb. 19, 2019, in US2019/0060240

Patent Owner's Preliminary Response

Citizen Petition

Maia Invalidity Contentions

Maia Opening Markman Brief

U.S. Provisional Patent Application No. 62/550,484

Patent Owner's Submission of Updated Mandatory Notice Information

Patent Owner's Updated Power Of Attorney

Patent Owner's Submission of Mandatory Notice Information

Patent Owner's Submission of Mandatory Notice Information

Patent Owner's Power of Attorney

Notice of Accord Filing Date

Petition

Prosecution History excerpts for the 046 patent

CV of Christian Schoneich, Ph.D.

Petitioner Power of Attorney

U.S. Patent No. 6,803,046 to Metcalfe et al.

Declaration of Christian Schoneich, Ph.D.

Bacarese-Hamilton et al., Oxidation/Reduction of Methionine Residues in CCK: A Study by Radioimmunoassay and Isocratic Reverse Phase High Pressure Liquid Chromatography, 6 Peptides 17 (1985)

U.S. Patent No. 7,329,644 to Saviano et al.

Akers et al., Peptides and Proteins as Parenteral Solutions, in Pharmaceutical Formulation Development of Peptides and Proteins (2000)

Wang et al., Review of Excipients and pHs for Parenteral Products Used in the United States, 34 PDA J. Pharm. Sci and Tech. 452 (1980)

Nema et al., Excipients and Their Use in Injectable Products, 51 PDA J. of Pharma. Sci. and Tech. 166 (1997)

U.S. Patent Publication No. 2003/0104996 to Li et al.

Physicians Desk Reference For Radiology and Nuclear Medicine, 1977/78 (1977) (PDR)

PCT Publication No. WO 00/5169 to Sato

PCT Publication No. WO 00/5169 to Sato (English Translation with affidavit)

Bacarese-Hamilton et al., Prevention of Cholecystokinin Oxidation During Tissue Extraction, 448 Neuronal Cholecystokinin 571 (1985)

Rational Design of Stable Protein Formulations: Theory and Practice, Chapters 5 & 8 (Carpenter and Manning, ed., April 30, 2002)

Liddle, R. A., On the Measurement of Cholecystokinin, 44 Clinical Chemistry 5 (1998)

DeLuca, et al., Formulation of Small Volume Parenterals, in Pharmaceutical Dosage Forms: Parenteral Medications Volume 1 (1992)

U.S. Patent No. 3,937,819 to Ondetti et al.

Wunsch, E., Peptide Factors as Pharmaceuticals: Criteria for Application, 22 Biopolymers 493 (1983)

Yagami, et al., Stabilization of a tyrosine O-sulfate residue by a cationic functional group: , 56 J. Peptide Res. 239 (2000)

Huttner, W. B., Determination and Occurrence of Tyrosine O-Sulfate in Proteins, 107 Methods in Enzymology 200 (1984)

Moroder et al., Gastrin and Cholecystokinin, An Arduous Task for the Peptide Chemist in Natural Product Chemistry (1986)

Package Insert for KINEVAC Sincalide for Injection, November 1994

Uffelman, W., Unexpected Shortfalls of Two Nuclear Medicine Pharmaceuticals, 42 J. Nuc. Med. 16N (2001)

Handbook of Pharmaceutical Excipients, Third Edition, Arthur H. Kibbe, Ed. (2000)

Jensen et al., Metal-Catalyzed Oxidation of Brain-Derived Neurotrophic Factor (BDNF)

Wang et al., Parenteral Formulations of Proteins and Peptides: Stabilities and stabilizers, 42 J. Parenteral Sci. and Tech. S4 (1988)

Yoshioka, et al., Stability of Peptide and Protein Pharmaceuticals in Stability of Drugs and Dosage Forms (2002)

Marseigne, et al., Full Agonists of CCK8 Containing a Nonhydrolyzable Sulfated Tyrosine Residue, 32 J. Med. Chem. 445 (1989)

Gorman et al., Proton Affinities of the 20 Common -Amino Acids, 114 J. Am. Chem. Soc. 3986 (1992)

Liddle, R. A., Cholecystokinin Cells, 59 Annu. Rev. Physiol. 221 (1997)

Wang, Y.J., Parenteral Products of Peptides and Proteins, in Pharmaceutical Dosage Forms: Parenteral Medications Volume 1 (1992)

Essentials of Nuclear Medicine Science (Hladik, et al., eds., 1987)

U.S. Patent No. 5,272,135 to Takruri

FDA Approval Package for NDA Application Number 017697-S012.

Fendler et al., Hydrolysis of Nitrophenyl and Dinitrophenyl Sulfate Esters, 33 J. Org. Chem. 10 3852 (1968)

Jensen et al., Metal-Catalyzed Oxidation of Brain-Derived Neurotrophic Factor (BDNF): Selectivity and Conformational Consequences of Histidine Modification, (2000)

Swadesh, et al., Sodium Sulfite as an Antioxidant in the Acid Hydrolysis of Bovine Pancreatic Ribonuclease A, 141 Analytical Biochemistry 397 (1984)

Mattern et al., Formulation of Proteins in Vacuum-Dried Glasses. II. Process and Storage Stability in Sugar-Free Amino Acid Systems,

Banga, A.K., Structure and Analysis of Therapeutic Peptides and Proteins (2006)

Wang et al., Lyophilization and Development of Solid Protein Particles, 203 Int. J. of Pharm. 1 (2000)

Bush et al., A critical evaluation of clinical trials in reactions to sulfites, 78 J. Allergy Clin. Immunol. 191 (1986)

Liddle, et al., Cholecystokinin Bioactivity in Human Plasma, 75 J. Clin. Invest. 1144 (1985)

Konturek, et al., Effect of Cholecystokinin Receptor Antagonist on Pancreatic Responses (1988)

Graf, et. al., ¿¿¿Iron-catalyzed Hydroxyl Radical Formation,¿¿¿ 259 J. Bio. Chem. 3620 (1984)

U.S. Patent No. 6,238,664 to Hellerbrand et al.